Association between Sarcopenia and Non-Alcoholic Fatty Liver Disease in Patients with Type 2 Diabetes Mellitus
Recruiting
- Conditions
- on-alcoholic fatty liver disease (NAFLD) is becoming more common in the general population around the world, especially in Asia. Sarcopenia is a condition characterized by a loss of muscle mass, strength, and function that occurs over time. Several studies have reported that sarcopenia is associated with nonalcoholic fatty liver disease in the general population. However, studies have investigated the association between sarcopenia and NAFLD in individuals with Type 2 diabetes mellitus (T2DM) is limitedNAFLD, sarcopenia, low muscle mass, low muscle function, low muscle power, low handgrip, low gait speed, type 2 DM
- Registration Number
- TCTR20220405005
- Lead Sponsor
- Thai Association for the Study of the Liver (THASL)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 641
Inclusion Criteria
Age more than 18 years old with type 2 diabetes mellitus from the outpatient clinic at Siriraj hospital
Exclusion Criteria
Patients with viral hepatitis, alcoholic liver disease, metabolic liver disease, autoimmune liver disease, and hepatocellular carcinoma
Patients with pregnancy
Patients with significant alcohol consumption
Patients with malignancy
Patients with disability
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Presence of NAFLD at time of investigation CAP
- Secondary Outcome Measures
Name Time Method Severity of NAFLD at time of investigation TE, FAST score